Lung Cancer Clinical Trial

Clinical Trial Finder Lung Cancer Trials

Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer

See Locations Near You

Summary

The purpose of this study is to determine the safety and effectiveness of the combination of oxaliplatin and irinotecan (CPT-11) in patients with previously untreated, advanced small cell lung cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Previously untreated extensive small cell lung cancer
No prior chemotherapy
No prior radiotherapy except for the treatment of brain metastases

Exclusion Criteria:

Prior treatment for extensive stage small cell lung cancer
Known hypersensitivity to any of the components of oxaliplatin or CPT-11
Greater than grade 2 peripheral neuropathy
Known HIV or Hepatitis B or C (active, previously treated or both)

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

24

Study ID:

NCT00316433

Recruitment Status:

Terminated

Sponsor:

Swedish Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Swedish Medical Center Cancer Institute
Seattle Washington, 98104, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

24

Study ID:

NCT00316433

Recruitment Status:

Terminated

Sponsor:


Swedish Medical Center

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
When Should I Consider Clinical Trials?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider